Abstract
Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA), homovanillic acid (HVA), and tryptophan in both CSF and plasma were measured in a carefully selected group of 33 depressed women. Strict and explicit inclusion and exclusion criteria were used, and CSF was taken under controlled circumstances. Seventeen operationally defined and uniformly rate psychiatric symptoms as well as global depression severity and 12 clinical background variables were correlated with the four biochemical parameters, using multivariate regression analysis based on Spearman's rank correlation coefficient according to the nature of the data. Global depression severity did not correlated with any of the biochemical variables; there were, however, significant correlations between CSF 5HIAA and anxiety, insomnia, and suicide on the one hand, and between CSF HVA and motor symptoms and paranoidity on the other hand. Background variables showed only a few--and much weaker--correlations. It was concluded that central monoamine metabolism does affect some particular psychiatric symptoms but is not parallel with the complex clinical construct of the depressive disease. Further studies using isolated psychopathological symptoms instead of nosological categories...Continue Reading
References
Dec 1, 1979·Psychiatry Research·H M van Praag, S de Haan
Jun 28, 1979·Psychopharmacology·A CoppenM Sandler
Mar 29, 1979·Psychopharmacology·M B Bowers, R E Study
Sep 16, 1975·Biochimica Et Biophysica Acta·N R StevensonJ S Fierstein
Jan 1, 1978·Acta Psychiatrica Scandinavica. Supplementum·M AsbergG Sedvall
Jun 27, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·A Carlsson, M Lindqvist
Aug 1, 1979·Australian and New Zealand Journal of Medicine·B P McGrathR Cooper
Feb 15, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·V F KemererT R Koch
Jul 1, 1979·Acta Psychiatrica Scandinavica·G d'EliaH Raotma
Aug 22, 1978·Archiv für Psychiatrie und Nervenkrankheiten·K KoehlerC Jacoby
Nov 1, 1978·Acta Psychiatrica Scandinavica·L von KnorringL Jacobsson
Jan 1, 1977·Journal of Neural Transmission·C M Banki
Dec 30, 1976·Archiv für Psychiatrie und Nervenkrankheiten·U Baumann
Feb 1, 1975·Biochemical Medicine·B H Westerink, J Korf
May 1, 1975·Psychological Medicine·H M PraagT Schut
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Feb 6, 1976·Science·M AsbergV Ringberger
Jan 1, 1973·The American Journal of Psychiatry·R M PostE K Gordon
Jan 1, 1971·Psychopharmacologia·J Korf, H M van Praag
Jan 1, 1980·Journal of Chronic Diseases·A M Jette
Feb 1, 1980·The American Journal of Psychiatry·P A BergerJ D Barchas
Citations
Jan 1, 1985·Psychopharmacology·G BagdyM Arató
Jan 1, 1986·Journal of Neural Transmission·B SaletuL Linzmayer
Jul 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·B A DavisA A Boulton
Oct 1, 1991·Psychiatry Research·G Wik, F A Wiesel
Jul 27, 2001·Psychiatry Research·A SerrettiE Smeraldi
Oct 30, 2004·Laterality·G C WestergaardJ D Higley
Dec 28, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·M MaesR Verkerk
May 29, 2004·Alcoholism, Clinical and Experimental Research·Mark D UnderwoodVictoria Arango
Nov 1, 1982·Acta Psychiatrica Scandinavica·W F GattazH Beckmann
Jan 1, 1985·Acta Psychiatrica Scandinavica. Supplementum·S E Møller
Nov 5, 1997·The Psychiatric Clinics of North America·V ArangoJ J Mann
Mar 3, 2007·American Journal of Primatology·Sue HowellJ Dee Higley
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gregory C WestergaardJ Dee Higley
Mar 1, 1988·The Australian and New Zealand Journal of Psychiatry·B Boman
Apr 19, 1989·Journal of Chromatography·B A Davis
Feb 1, 1992·Synapse·S Caldecott-Hazard, L S Schneider